XML 55 R44.htm IDEA: XBRL DOCUMENT v3.8.0.1
Subsequent Events - Narrative (Details) - Envisia Therapeutics Inc. - Subsequent Event
$ in Millions
Oct. 04, 2017
USD ($)
shares
Subsequent Event [Line Items]  
Cash consideration in business combination $ 10.5
Shares issued under purchase agreement | shares 263,146
Equity interests exchanged $ 14.3